US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

65.13

-1.6430-2.46%

Post-market: 65.00-0.1270-0.20%19:30 EDT

Volume:41.52K

Turnover:2.70M

Market Cap:92.79M

PE:- -

High:66.06

Open:66.06

Low:64.03

Close:66.77

52wk High:66.88

52wk Low:36.00

Shares:1.42M

Float Shares:1.42M

Volume Ratio:1.41

T/O Rate:2.91%

Dividend:0.65

Dividend Rate:0.99%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Did Illumina’s (ILMN) New Debt Deal and Credit Line Refresh Just Shift Its Investment Narrative?

Simply Wall St.

Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2

Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test

Simply Wall St.

Genprex selects manufacturing organization for diabetes gene therapy

Illumina Completes $300 Million Debt Refinancing Offering

Illumina Completes $300 Million Notes Offering Due 2029

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)

Stanley Druckenmiller Ditched These Chip Plays Before the Selloff. Here's How He's Playing the Tech Sector Now.

Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist

Simply Wall St.

Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million

Twist Bioscience CEO Emily Leproust Disposes of Common Shares Worth $2.5 Million

Natera (NTRA) Gets a Buy from Citi

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

Illumina Secures New Syndicated Credit Facility Agreement

Illumina - Enters Credit Agreement on August 13, 2026

Illumina Enters USD 1 Billion Five-Year Revolving Credit Facility with Bank of America-Led Lenders

Illumina - Credit Agreement Provides for $1 Bln Five-Year Revolving Credit Facility - SEC Filing

THOMSON REUTERS

Illumina - Credit Agreement Includes Option to Increase Commitments or Term Loans up to $500 Mln - SEC Filing

THOMSON REUTERS

Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/GNOM/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":65.127,"timestamp":1787601600000,"preClose":66.77,"halted":0,"volume":41524,"hourTrading":{"tag":"盘后","latestPrice":65,"preClose":65.127,"latestTime":"19:30 EDT","volume":279,"amount":18140.437,"timestamp":1787614206811,"change":-0.127,"changeRate":-0.00195,"amplitude":0.001996},"delay":0,"changeRate":-0.02460685936797964,"floatShares":1424771,"shares":1424771,"eps":0,"marketStatus":"Closed","change":-1.643,"latestTime":"08-24 16:00:00 EDT","open":66.06,"high":66.06,"low":64.0301,"amount":2702159.7666,"amplitude":0.030401,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":66.77,"sharesOutstanding":1094672,"nav":66.56,"aum":94832765.15,"dividendRate":0.009945,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":66.06,"preClose":66.77,"latestTime":"09:29 EDT","volume":502,"amount":33166.99944,"timestamp":1787578199999,"change":-0.71,"changeRate":-0.010634,"amplitude":0.001647},"postHourTrading":{"tag":"盘后","latestPrice":65,"preClose":65.127,"latestTime":"19:30 EDT","volume":279,"amount":18140.437,"timestamp":1787614206811,"change":-0.127,"changeRate":-0.00195,"amplitude":0.001996},"volumeRatio":1.406659,"impliedVol":0.3313,"impliedVolPercentile":0.844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1424771,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.406659,"shares":1424771,"dividePrice":0.6477,"high":66.06,"amplitude":0.030401,"preClose":66.77,"low":64.0301,"week52Low":36,"pbRate":"--","week52High":66.88,"institutionHeld":0,"latestPrice":65.127,"eps":0,"divideRate":0.009945,"volume":41524,"delay":0,"ttmEps":0,"open":66.06,"prevYearClose":45.4562,"prevWeekClose":66.77,"prevMonthClose":54.17,"prevQuarterClose":56.834,"fiveDayClose":59.09,"twentyDayClose":53.6914,"sixtyDayClose":49.5125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660175784","title":"Did Illumina’s (ILMN) New Debt Deal and Credit Line Refresh Just Shift Its Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660175784","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660175784?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:14","pubTimestamp":1787116473,"startTime":"0","endTime":"0","summary":"In August 2026, Illumina, Inc. completed a US$299.913 million offering of 4.950% senior unsecured notes due September 19, 2029 and put in place a new US$1.00 billion unsecured revolving credit facility maturing in 2031, replacing its prior 2023 arrangement.\nTogether, the fresh bond issuance and expanded revolving credit capacity indicate Illumina is actively reshaping its funding mix to support future corporate needs and balance-sheet flexibility.\nNext, we’ll examine how Illumina’s expanded...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/did-illuminas-ilmn-new-debt-deal-and-credit-line-refresh-jus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/did-illuminas-ilmn-new-debt-deal-and-credit-line-refresh-jus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AIPO","GNOM","CHAT","QTOC","LU0128526141.USD","BK4535","VTHR","BK4534","ILMN","AGIX","LU0029874061.USD","GNMX","ARTY","BK4585","BK4121","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660413569","title":"Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660413569","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660413569?lang=en_us&edition=fundamental","pubTime":"2026-08-19 08:35","pubTimestamp":1787099724,"startTime":"0","endTime":"0","summary":"UPDATE 3-Trump picks White House adviser Heidi Overton to run FDA, source saysAug 18 (Reuters)-U.S. President Donald Trump has chosen White House policy aide Heidi Overton to lead the Food and Drug Ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL6N44G00Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT","WDNA","BK4532","IE0009355771.USD","BK4534","BK4568","IE00BFTCPJ56.SGD","BK4505","IE00BJJMRZ35.SGD","IDNA","BK4588","IE00BJT1NW94.SGD","BK4551","SRPU","BK4563","LGHT","GNOM","REPL","IE00B2B36J28.USD","BK4548","MRNX","BK4585","RGNX","BK4533","BK4501","MRNY","MRNA","IE0002141913.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660970474","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2660970474","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660970474?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:15","pubTimestamp":1787091347,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,148.2Guardant Health director Tariq Musa sold 116 common shares on Aug. 17 at USD 156.45.The sale cut his directly held stak","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbdy8Tn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","GNMX","LU0889565916.HKD","BK4588","GH","HELX","GDOC","EKG","BK4196","GNOM","LFSC","LU0320765992.SGD","BK4551","BK4585","BK4535","LU0109394709.USD","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495332","title":"Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495332","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495332?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:26","pubTimestamp":1787059570,"startTime":"0","endTime":"0","summary":"Why Guardant Health Stock Is Back on Investors’ Radar\nGuardant Health (GH) moved into focus after several Q2 2026 developments, including FDA approval of an updated Guardant360 liquid biopsy test and new American Cancer Society support for its Shield colorectal cancer screening.\nThese clinical and guideline milestones arrived alongside stronger than expected Q1 results related to test volume and coverage trends. This provided investors with fresh information on how the company’s product...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-back-in-focus-as-new-approvals-put-valuat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-back-in-focus-as-new-approvals-put-valuat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765992.SGD","BK4535","LFSC","EKG","LU0109394709.USD","BK4551","FFOX","HELX","GH","PTH","BK4588","BK4585","GNOM","LU0889565916.HKD","GNMX","GDOC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461015","title":"Genprex selects manufacturing organization for diabetes gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461015","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461015?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:10","pubTimestamp":1787051418,"startTime":"0","endTime":"0","summary":"Genprex (GNPX) has entered into a development and manufacturing agreement with a U.S. based clinical and commercial Contract Development and Manufa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-selects-manufacturing-organization-for-diabetes-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-selects-manufacturing-organization-for-diabetes-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4139","CNCR","FBT","LFSC","BK4588","GNOM","GNPX","IBB","IBBQ","TBXU","BK4585","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660320844","title":"Illumina Completes $300 Million Debt Refinancing Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2660320844","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660320844?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:02","pubTimestamp":1787000556,"startTime":"0","endTime":"0","summary":"Illumina ( ($ILMN) ) has issued an announcement. On August 17, 2026, Illumina completed a public offering of $300 million in 4.950% notes due 2029,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/illumina-completes-300-million-debt-refinancing-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/illumina-completes-300-million-debt-refinancing-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4534","BK4535","LU0128526141.USD","LU0029874061.USD","ILMN","GNMX","BK4121","BK4585","GNOM","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660270434","title":"Illumina Completes $300 Million Notes Offering Due 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2660270434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660270434?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:04","pubTimestamp":1786997063,"startTime":"0","endTime":"0","summary":"Illumina completes $300 million notes offering due 2029Illumina priced a public offering of USD 300 million of 4.950% notes due 2029.Net proceeds, with cash on hand, earmarked to repay its 4.650% note","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL8L80rl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4585","BK4534","ILMN","GNOM","LU0029874061.USD","LU0128526141.USD","GNMX","BK4588","BK4548","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660436627","title":"Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660436627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660436627?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:20","pubTimestamp":1786980007,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Adagene (ADAG) and Natera (NTRA). Adagene (ADAG) M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0345770993.USD","LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","LU2264538146.SGD","LU0106261612.USD","BK4581","BK4139","LU0963586101.USD","LU0345770308.USD","HCSG","LU1988902786.USD","NTRA","LU0029874061.USD","BK4137","XLV","HELX","XBI","BK4585","LU0012050646.USD","LU0128526141.USD","LU2324357040.USD","LU2065731478.USD","BK4588","LU1064131342.USD","ADAG","LU0053671581.USD","LU2065171311.SGD","GNOM","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660802435","title":"Stanley Druckenmiller Ditched These Chip Plays Before the Selloff. Here's How He's Playing the Tech Sector Now.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660802435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660802435?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:29","pubTimestamp":1786976940,"startTime":"0","endTime":"0","summary":"Healthcare remains a top bet for the closely followed investorStanley Druckenmiller's Duquesne Family Office is leaning a little more into tech lately.Earlier this year, Stanley Druckenmiller spoke of","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1282649810.SGD","LU0289960550.SGD","IE0004086264.USD","LU1868837565.USD","LU2458330243.SGD","BK4543","LU1988902786.USD","LU2491049909.HKD","IE00B3M56506.USD","LU1989772923.USD","LU2663582299.SGD","LU0082616367.USD","BK4581","LU1211504680.USD","LU2065171402.SGD","LU2087625088.SGD","BK4533","EMC","LU0359201885.HKD","LU0878005551.USD","LU2023251221.USD","LU0348723411.USD","BK4503","CHPX","LU1852331112.SGD","LU2506951792.HKD","LU0211328371.USD","LU0072462343.USD","IE00BFXG0V08.USD","LU0541501648.USD","LU1868837722.USD","LU2089283258.USD","CGNG","LU1267930813.SGD","LU0965509283.SGD","LU2237443622.USD","LU1934455863.HKD","LU1917777945.USD","LU2491050154.USD","WUGI","AIQ","LU0965508806.USD","LU0175139822.USD","STM","LU2125154778.USD","LU0238689110.USD","EMM","UMMA","IE00BQXX3F31.USD","GNOM","LU0384037296.USD","LU2237443549.SGD","LU2054465674.USD","LU2028103732.USD","LU2211815571.USD","BK4554","LU0094547139.USD","ESIM","LU0792757196.USD","LU2065171311.SGD","BK4591","LU1037948541.HKD","LU0359202008.SGD","LU2491050071.SGD","CWI","LU0359201612.USD","LU0211327993.USD","SPWO","LU1508157978.USD","SGXZ51526630.SGD","BK4512","TSM","LU0198837287.USD","LU1037948897.HKD","LU2133065610.SGD","IE00BQXX3D17.EUR","LU2750360997.AUD","SG9999004220.SGD","AVSE","IE00BHPRN162.USD","IE0004091025.USD","LU0882747503.HKD","BK4585","LU1048588211.SGD","IE0004445239.USD","LU0345770308.USD","LU0823414478.USD","TSMY","BK4139","LU0124676726.USD","LU0158827948.USD","LU1712237335.SGD","LU1282649067.USD","03145","IE00BMPRXR70.SGD","LU0823421333.USD","BK4604","LU0323591593.USD","LU2065169927.USD","SGXZ99366536.SGD","LU1868838027.USD","LU0316494557.USD","LU2041044095.USD","LU2106854487.HKD","LU1989764664.SGD","LU2089284900.SGD","ADVE","LU2247934214.USD","LU2249611893.SGD","BK4548","LU0488056044.USD","LU1023057109.AUD","LU2471134879.HKD","BK4141","LU0143863784.USD","LU2125154935.USD","LU2360108059.USD","LU2063271972.USD","LU2458330169.SGD","LU0965509010.AUD","LU2264538146.SGD","TSMZ","LU1989764748.USD","LU2211814178.USD","LU2092937221.SGD","LU2750360641.GBP","BAI","MEMX","LU0109392836.USD","LU2298321311.HKD","IE00BQXX3C00.GBP","LU0878004406.USD","CGDG","LU0889565833.HKD","SG9999000418.SGD","IE00BYQQ9H92.USD","LU0143863198.USD","LU2471134952.CNY","BK4550","BLOX","CGIC","LU0823414551.USD","LU2471134796.USD","BK4526","STSM","LU0889566641.SGD","LU2023250504.SGD","LU2271345857.HKD","SMH","LU0861579265.USD","LU2324357040.USD","LU2860962120.EUR","BK4602","LU0310799852.SGD","IE00BZ199S13.USD","TSMG","CNEQ","LU2471134523.USD","LU1934455277.USD","TEK","LU1934455194.USD","CGGO","LU2360032135.SGD","TTEQ","BK4527","LU1803068979.SGD","LU0353189680.USD","SGXZ81514606.USD","LU1323610961.USD","LU0572940350.SGD","CORO","LU2065731478.USD","TSMX","LU0963586101.USD","ASIA","LU1064131342.USD","IE00BKPKM429.USD","HELX","LU0345770993.USD","LU0642271901.SGD","LU1267930490.SGD","IE00BMPRXN33.USD","LU2065170008.USD","LU2250418816.HKD","LU2294711713.HKD","LU0541502299.USD","KNOW","LU0353189763.USD","BK4505","LU0056508442.USD","SPTE","LU0006061336.USD","LU2357125470.USD","LU0106261612.USD","LU1974910355.USD","LU1989772840.SGD","TINS","LU2543165471.USD","NTRA","BK4534","TSMU","FDTX","LU0158827781.USD","AVEM","LU2111349929.HKD","IE00BD6J9T35.USD","LU0572939691.SGD","BK4532","BK4605","LU1623119135.USD","LU2237443382.USD","LU0823421416.USD","LU2360106780.USD","BK4588","LU0719512351.SGD","BK4612","LU1316542783.SGD","LU0012050646.USD","AVXC","LU0965509101.SGD","LU0264606111.USD","LU2237443978.SGD","IE00B5TLWC47.USD","LU0689626769.HKD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179630","title":"Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179630","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659179630?lang=en_us&edition=fundamental","pubTime":"2026-08-16 05:20","pubTimestamp":1786828815,"startTime":"0","endTime":"0","summary":"Health Canada has cleared Moderna (MRNA) to begin a Phase I clinical trial of its mRNA Ebola vaccine targeting the Bundibugyo virus, giving investors another data point on the company’s expanding infectious disease pipeline.\nSee our latest analysis for Moderna.\nModerna’s US$63.32 share price has been volatile, with a 7.01% 7 day share price gain and a 29.12% 90 day share price return. The 125.98% 1 year total shareholder return contrasts with a weaker 3 and 5 year record. Recent regulatory...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-mrna-starts-ebola-vaccine-trial-as-fair-value-questi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-mrna-starts-ebola-vaccine-trial-as-fair-value-questi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LGHT","BK4501","BK4585","BK4534","BK4551","BK4532","GNOM","BK4139","IDNA","MRNX","BK4533","BK4588","BK4568","WDNA","BK4548","MRNA","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659812795","title":"Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659812795","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659812795?lang=en_us&edition=fundamental","pubTime":"2026-08-15 09:35","pubTimestamp":1786757742,"startTime":"0","endTime":"0","summary":"Natera co-founder, Director Sheena Jonathan sells 6,000 shares worth $1.95 millionNatera director and co-founder Sheena Jonathan sold 6,000 common shares on Aug. 10, 2026 at USD 325.32 each.Directly h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260815:nNDL1dBDL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","LU2264538146.SGD","LU0106261612.USD","GNOM","LU0963586101.USD","LU0345770308.USD","LU1988902786.USD","NTRA","LU0012050646.USD","LU2324357040.USD","LU2065731478.USD","LU1064131342.USD","LU0053671581.USD","LU2065171311.SGD","BK4139","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126777","title":"Twist Bioscience CEO Emily Leproust Disposes of Common Shares Worth $2.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126777","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126777?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:09","pubTimestamp":1786738148,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily Leproust disposes of common shares worth $2.5 millionTwist Bioscience CEO Emily M. Leproust exercised stock options for 19,952 shares on Aug. 12, 2026 at USD 26.66.She sold ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL2Cx15Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily Leproust Disposes of Common Shares Worth $2.5 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","TWST","BK4585","WDNA","GNOM","BK4139","BK4588","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659729143","title":"Natera (NTRA) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2659729143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659729143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:57","pubTimestamp":1786705032,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick B Donnelly from Citi maintained a Buy rating on Natera, with a price target of $365.00. According to TipRanks, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/natera-ntra-gets-a-buy-from-citi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/natera-ntra-gets-a-buy-from-citi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065169927.USD","LU1064131342.USD","LU2065171402.SGD","LU0345770308.USD","LU2065731478.USD","LU0106261612.USD","LU0053671581.USD","LU0012050646.USD","LU2264538146.SGD","BK4139","LU0345770993.USD","LU2065171311.SGD","GNOM","LU1988902786.USD","LU0963586101.USD","NTRA","LU2324357040.USD","LU2065170008.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659719596","title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659719596","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659719596?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:21","pubTimestamp":1786663307,"startTime":"0","endTime":"0","summary":"Guardant Health Chief People Officer Terilyn Monroe disposes of common shares worth $7.61 millionGuardant Health Chief People Officer Terilyn J. Monroe cut her direct common stock stake to 22,979 shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1rsYJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4535","HELX","LU0889565916.HKD","GH","PTH","LFSC","GDOC","LU0320765992.SGD","BK4551","BK4588","GNMX","GNOM","BK4585","EKG","FFOX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160249","title":"Illumina Secures New Syndicated Credit Facility Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160249","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160249?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:58","pubTimestamp":1786654723,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Illumina ( ($ILMN) ). On August 13, 2026, Illumina, Inc. entered into a credit agreement with a syndicate of le...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/illumina-secures-new-syndicated-credit-facility-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/illumina-secures-new-syndicated-credit-facility-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ILMN","BK4548","BK4588","LU0029874061.USD","BK4585","BK4121","LU0128526141.USD","GNMX","GNOM","BK4535","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659716090","title":"Illumina - Enters Credit Agreement on August 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659716090","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659716090?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:58","pubTimestamp":1786654702,"startTime":"0","endTime":"0","summary":"BRIEF-Illumina - Enters Credit Agreement On August 13, 2026Aug 13 -Illumina IncILMN.O:ILLUMINA - ENTERS CREDIT AGREEMENT ON AUGUST 13, 2026 - SEC FILINGILLUMINA - CREDIT AGREEMENT PROVIDES FOR $1 BILLION FIVE-YEAR REVOLVING CREDIT FACILITY - SEC FILINGILLUMINA - CREDIT AGREEMENT INCLUDES OPTION TO INCREASE COMMITMENTS OR TERM LOANS UP TO $500 MILLION - SEC FILINGFurther company coverage:ILMN.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GNOM","BK4535","BK4534","BK4121","ILMN","LU0128526141.USD","LU0029874061.USD","GNMX","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167148","title":"Illumina Enters USD 1 Billion Five-Year Revolving Credit Facility with Bank of America-Led Lenders","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167148","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167148?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:29","pubTimestamp":1786652993,"startTime":"0","endTime":"0","summary":"Illumina enters USD 1 billion five-year revolving credit facility with Bank of America-led lendersIllumina entered a new senior unsecured five-year revolving credit facility of $1 billion on Aug. 13, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL4XmN3n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYF","IE00B19Z3581.USD","BK4588","LU0052756011.USD","VFH","LU0098860793.USD","XLF","LU0787776722.HKD","LU0306807586.USD","IE00BLSP4239.USD","LU1201861165.SGD","LU0149725797.USD","LU1162221912.USD","LU0130102774.USD","LU0683600562.USD","LU1280957306.USD","LU2129689514.USD","LU1267930227.SGD","UYG","LU1894683348.USD","LU0128526141.USD","FTXO","BK4548","KBWB","LU0320765489.SGD","LU2133065610.SGD","TFNS","FNCL","BK4585","BK4559","ILMN","LU0321505439.SGD","LU1718418525.SGD","LU1074936037.SGD","LU1894683264.USD","GNOM","GNMX","BAC","LU0256863902.USD","LU0310800965.SGD","IYG","LU2265009873.SGD","LU0417517546.SGD","LU0170899867.USD","IE00BFXG1179.USD","LU0053666078.USD","LU1363072403.SGD","LU0029874061.USD","LU1291159041.SGD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659673001","title":"Illumina - Credit Agreement Provides for $1 Bln Five-Year Revolving Credit Facility - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673001?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:21","pubTimestamp":1786652505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1N2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4121","ILMN","LU0128526141.USD","BK4548","BK4534","LU0029874061.USD","BK4535","GNMX","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167664","title":"Illumina - Credit Agreement Includes Option to Increase Commitments or Term Loans up to $500 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167664?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:21","pubTimestamp":1786652505,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1N2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4535","BK4121","BK4588","GNOM","BK4548","ILMN","BK4585","LU0029874061.USD","GNMX","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162947","title":"Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162947","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162947?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"clinical trial were presented at the 2026 European Hematology Association.  Annual Meeting. Data presented reinforced vispa-cel is the only. single-dose, off-the-shelf therapy to demonstrate deep and durable. responses on par with autologous CAR-T cell therapies in second-line . large B cell lymphoma . Efficacy and safety data in 2L LBCL. patients who had received a single dose of 80 million optimized vispa-cel. -- Optimized vispa-cel is defined as cells from a donor younger than 30. years old with at least two matched human leukocyte antigen  alleles. between patient and donor. The 27-patient subgroup best represents the. treatment regimen and patient population for Caribou's planned ANTLER-3. -- Caribou previously reached alignment with the U.S. Food and Drug. Administration  regarding its planned ANTLER-3 pivotal phase 3. clinical trial design, which is expected to be a randomized, control","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","FBT","BK4195","CNCR","BK4211","MEDX","CAR","GNOM","CRBU","SYNB","BK4161","NVIB","BK4539","LFSC","GDOC","LD","HYLG","BK4585","CR","BK4022","IDNA","ORR","PFS","IBBQ","TBXU","BK4230","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":10,"totalSize":213,"code":"91000000","status":"200"}]}}